Revenue Breakdown
Composition ()
No data
Revenue Streams
Anixa Biosciences Inc (ANIX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Flat-Panel Display, accounting for 98.9% of total sales, equivalent to $246.67K. Another important revenue stream is Encryption Products. Understanding this composition is critical for investors evaluating how ANIX navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, Anixa Biosciences Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -62.16%, provide a clear picture of how effectively ANIX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ANIX competes directly with industry leaders such as GANX and DTIL. With a market capitalization of $94.46M, it holds a significant position in the sector. When comparing efficiency, ANIX's gross margin of N/A stands against GANX's N/A and DTIL's 100.00%. Such benchmarking helps identify whether Anixa Biosciences Inc is trading at a premium or discount relative to its financial performance.
